These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3181267)

  • 1. Influence of 2-deoxy-D-glucose and arterial ischaemia on glucose oxidation and growth of liver cancer in the rat.
    Mack P; Ahrén B; Jeppsson B; Kan Z; Bengmark S
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1433-7. PubMed ID: 3181267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose turnover in rats undergoing transient dearterialization for liver malignancy.
    Mack P; Ahrén B; Jeppsson B; Bengmark S
    J Surg Res; 1989 Nov; 47(5):447-52. PubMed ID: 2811358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hepatic artery occlusion and desferrioxamine on liver-tumour growth.
    Lindnér P; Naredi P; Peterson A; Hafström L
    Int J Cancer; 1995 Nov; 63(4):592-6. PubMed ID: 7591271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent hepatic dearterialization induces glucose intolerance: an experimental study in the rat.
    Sjövall S; Ahrén B; Bengmark S
    Br J Surg; 1990 Apr; 77(4):405-8. PubMed ID: 2187562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feeding elicited by 2-deoxyglucose occurs in the absence of reduced glucose oxidation.
    Nonavinakere VK; Ritter RC
    Appetite; 1983 Sep; 4(3):177-85. PubMed ID: 6421229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thirst and plasma arginine vasopressin levels during 2-deoxy-D-glucose-induced glucoprivation in humans.
    Thompson DA; Campbell RG; Lilavivat U; Welle SL; Robertson GL
    J Clin Invest; 1981 Apr; 67(4):1083-93. PubMed ID: 7204569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined intermittent dearterialization and intraperitoneal 5-fluorouracil administration for liver tumours in the rat.
    Mack P; Jeppsson B; Widlus D; Hägerstrand I; Bengmark S
    Eur J Cancer Clin Oncol; 1988 May; 24(5):909-13. PubMed ID: 3169096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intra-arterial norcantharidin in suppressing tumour 14C-labelled glucose oxidative metabolism in rat Morris hepatoma.
    Mack P; Ha XF; Cheng LY
    HPB Surg; 1996; 10(2):65-72. PubMed ID: 9184858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned taste aversion produced by 2-deoxy-D-glucose in rats and hamsters.
    Dibattista D
    Physiol Behav; 1988; 44(2):189-92. PubMed ID: 2853380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatic vagotomy and/or coeliac ganglionectomy on the delayed eating response to insulin and 2DG injection in rats.
    Granneman J; Friedman MI
    Physiol Behav; 1984 Sep; 33(3):495-7. PubMed ID: 6393163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of 2-deoxy-D-glucose on liver tumor growth in rats.
    Cay O; Radnell M; Jeppsson B; Ahrén B; Bengmark S
    Cancer Res; 1992 Oct; 52(20):5794-6. PubMed ID: 1394204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin response to 2-deoxy-D-glucose in the rat.
    Baylis PH; Robertson GL
    Endocrinology; 1980 Dec; 107(6):1970-4. PubMed ID: 7428701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drinking and feeding induced by jugular and portal infusions of 2-deoxy-D-glucose.
    Russell PJ; Mogenson GJ
    Am J Physiol; 1975 Oct; 229(4):1014-8. PubMed ID: 1190312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uridylate trapping induced by the C-2-modified D-glucose analogs glucosone, fluoroglucose, and glucosamine.
    Holstege A; Schulz-Holstege C; Henninger H; Reiffen KA; Schneider F; Keppler DO
    Eur J Biochem; 1982 Jan; 121(2):469-74. PubMed ID: 7060558
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC; Tannenbaum GS
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of plasma triglyceride levels due to 2-deoxy-D-glucose in conscious rats.
    Haito K; Kagawa S; Takeda A; Shimizu S; Mimura K; Matsuoka A
    Life Sci; 1984 Oct; 35(18):1821-7. PubMed ID: 6492991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesions involving the suprachiasmatic nucleus eliminate the glucagon response to intracranial injection of 2-deoxy-D-glucose.
    Yamamoto H; Nagai K; Nakagawa H
    Endocrinology; 1985 Aug; 117(2):468-73. PubMed ID: 3893985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophagia follows the initial hyperphagia produced by 2-deoxy-D-glucose in rats.
    Thompson CI; Zagon IS; McLaughlin PJ
    Physiol Behav; 1979 Jul; 23(1):187-90. PubMed ID: 515210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of pancreatic endocrine cells of the neonatal rat: Part XIII--Effect of 2-deoxyglucose and iodoacetic acid on the functional maturation of neonatal rat B cells.
    Kagawa S; Nakao-Yamashita K; Wakabayashi S; Matsuoka A
    Indian J Biochem Biophys; 1988 Oct; 25(5):416-21. PubMed ID: 3072288
    [No Abstract]   [Full Text] [Related]  

  • 20. Feeding responses of rats with dorsomedial hypothalamic lesions given ip 2DG or glucose.
    Bellinger LL; Bernardis LL; Brooks S
    Am J Physiol; 1978 Sep; 235(3):R168-74. PubMed ID: 696855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.